Xospata
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Xospata, covering 2018-11-28 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm [Phase 1, Phase 2]